Nikko Asset Management Americas’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Nikko Asset Management Americas’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-58,656	Closed	-$6.35M	–	228
2020 Q3	$6.35M	Sell	58,656 -6,807	-10%	-$731K	0.06%	130
2020 Q2	$1K	Sell	65,463 -48,764	-43%	-$5.22M	﹤0.01%	174
2020 Q1	$12.3M	Sell	114,227 -12,451	-10%	-$1.43M	0.23%	74
2019 Q4	$14.7M	Sell	126,678 -2,767	-2%	-$320K	0.23%	82
2019 Q3	$14.8M	Buy	129,445 +19,846	+18%	+$1.97M	0.26%	75
2019 Q2	$10.4M	Buy	109,599 +55,176	+101%	+$5.2M	0.2%	84
2019 Q1	$4.97M	Buy	+54,423	New	+$4.45M	0.13%	110

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Nikko Asset Management Americas's CBPO Position: Q4 2020 in Review

Nikko Asset Management Americas sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 58,656 shares — an estimated $6.35M sold.

Nikko Asset Management Americas first reported a position in CBPO in Q1 2019 and held it in 7 quarters. The position peaked at $14.8M in Q3 2019. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

Nikko Asset Management Americas reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
Nikko Asset Management Americas sold 58,656 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $6.35M.
Nikko Asset Management Americas first reported a position in China Biologic Products Holdings, Inc. in Q1 2019 and held it in 7 quarters.
Nikko Asset Management Americas's China Biologic Products Holdings, Inc. position peaked at $14.8M in Q3 2019.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Nikko Asset Management Americas's 13F filing for Q4 2020, filed 11 Feb 2021.